New Technologies for the Study of Lymphatics in the Digestive and Urinary Systems (R43/R44)
The summary for the New Technologies for the Study of Lymphatics in the Digestive and Urinary Systems (R43/R44) grant is detailed below.
This summary states who is eligible for the grant, how much grant money will be awarded, current and past deadlines, Catalog of Federal Domestic Assistance (CFDA) numbers, and a sampling of similar government grants.
Verify the accuracy of the data FederalGrants.com provides by visiting the webpage noted in the Link to Full Announcement section or by contacting the appropriate person listed as the Grant Announcement Contact.
If any section is incomplete, please visit the website for the National Institutes of Health, which is the U.S. government agency offering this grant.
New Technologies for the Study of Lymphatics in the Digestive and Urinary Systems (R43/R44): This FOA is to encourage Small Business Innovation Research (SBIR) applications for research to develop reagents, tools and technologies to accelerate research on lymphatic vessel physiology and pathophysiology in digestive system and urinary tract organs. The announcement does not focus on immune mechanisms; however tools that will aid studies to understand the factors that direct local lymphatic vessel functional anatomy and physiology during health, inflammation and disease in digestive and urinary tract organs, and the mechanisms by which alterations of lymphatic vessel function affect organ function, are of interest.
Federal Grant Title: | New Technologies for the Study of Lymphatics in the Digestive and Urinary Systems (R43/R44) |
Federal Agency Name: | National Institutes of Health |
Grant Categories: | Food and Nutrition Health |
Type of Opportunity: | Discretionary |
Funding Opportunity Number: | PA-12-258 |
Type of Funding: | Grant |
CFDA Numbers: | 93.847 |
CFDA Descriptions: | Diabetes, Digestive, and Kidney Diseases Extramural Research |
Current Application Deadline: | Sep 07, 2015 |
Original Application Deadline: | Sep 07, 2015 |
Posted Date: | Aug 08, 2012 |
Creation Date: | Aug 08, 2012 |
Archive Date: | Oct 08, 2015 |
Total Program Funding: | |
Maximum Federal Grant Award: | $150,000 |
Minimum Federal Grant Award: | |
Expected Number of Awards: | |
Cost Sharing or Matching: | No |
- Applicants Eligible for this Grant
- Small businesses
- Grant Announcement Contact
- NIH OER [email protected]
If you have any problems linking to this funding announcement, please contact the NIH OER Webmaster [[email protected]] - Similar Government Grants
- • Pilot Studies of Biological, Behavioral and Social Mechanisms Contributing to HIV Pathogen...
- • Priority HIV/AIDS Research within the Mission of NIDDK (R01 Clinical Trial Optional)
- • Continuous Ketone Monitoring for the Safe Use of Sodium-glucose Cotransporter-2 Inhibitors...
- • NIDDK High Risk Multi-Center Clinical Study Cooperative Agreement (U01 Clinical Trial Requ...
- • NIDDK High Risk Multi-Center Clinical Study Implementation Planning Cooperative Agreements...
- • Proteomic and Metabolomic Approaches to Diagnose Diabetes and Pre-Diabetes
- • Molecular Therapy Core Centers
- • Pilot and Feasibility Program in Human Islet Biology
- More Grants from the National Institutes of Health
- • HEAL Initiative: Studies to Enable Analgesic Discovery (R61/R33 - Clinical Trial Not Allow...
- • Technologies and Assays for Therapeutic Genome Editing INDs (U01, Clinical Trial Not Allow...
- • Developmental AIDS Research Center on Mental Health and HIV/AIDS (P30 Clinical Trial Optio...
- • AIDS Research Center on Mental Health and HIV/AIDS (P30 Clinical Trial Optional)
- • NIH Directors Pioneer Award Program (DP1 Clinical Trial Optional)